Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 5 pp 6945—6956
Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway
Figure 7. PI3K/AKT signaling is the downstream target for the role of miR-483-5p-SATB2 axis in ovariectomized rats. (A) Western blotting results of the expressions of osteogenic differentiation indicators. (B) Quantitative analysis of the optical density in (A). (C) Western blotting results of the expressions of PI3K/AKT signaling. (D) Quantitative analysis of the optical density in (C). Data were presented as mean ± SD. a p < 0.05 versus control group, b p < 0.05 versus model group, c p < 0.05 versus inhibitor group.